StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$28.27+0.30 (+1.07%)

Close on Nov 17, 2026Market cap $1.68BP/E –Yield –

Earnings

Kestra Medical Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Dec 10, 2026
Q2 FY2027 · estimated, after the close
Revenue, Q1 FY2027
$31.00M
+59.8% on a year earlier
EPS, Q1 FY2027
–
Latest guidance
Raised
Sep 14, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Kestra Medical Technologies's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2027ended Oct 31, 2026Dec 10, 2026Expected––––
Q1 FY2027ended Jul 31, 2026Sep 14, 2026after the close$31.00M+59.8%–Release
Q4 FY2026ended Apr 30, 2026Jul 14, 2026after the close$28.60M+66.3%–Release
Q3 FY2026ended Jan 31, 2026Mar 17, 2026after the close$24.60M+62.9%-$0.61Release
Q2 FY2026ended Oct 31, 2025Dec 11, 2025after the close$22.60M–-$0.64Release
Q1 FY2026ended Jul 31, 2025Sep 11, 2025after the close$19.40M––Release
Q4 FY2025ended Apr 30, 2025Jul 15, 2025after the close$17.20M––Release
Q3 FY2025ended Jan 31, 2025Apr 14, 2025after the close$15.10M–-$1.25Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Kestra Medical Technologies's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
growthFY2027+48%–NewSep 14, 2026
revenue guidanceFY2027$141.00M$137.00MRaisedSep 14, 2026

Guidance vs results

The last range Kestra Medical Technologies gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2026Revenue$93.00M$95.20MΣ4QAbove range

Guidance history

Every forecast Kestra Medical Technologies put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Sep 14, 2026revenue guidanceFY2027$141.00MRaised
Sep 14, 2026growthFY2027+48%New
Jul 14, 2026revenueFY2027$137.00MNew
Mar 17, 2026revenue guidanceFY2026$93.00MRaised
Dec 11, 2025revenueFY2026$91.00MNew
Sep 11, 2025revenue guidanceFY2026$88.00MRaised
Jul 15, 2025revenueFY2026$85.00MNew
Apr 14, 2025revenueFY2025$58.00M – $58.50MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Kestra Medical Technologies filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?